semaglutide discontinuation study denmark 2025 september Half of people stop taking popular weight-loss drug within a year, finds Novo Nordisk presents four new

During titration (the initial dose-escalation period), your dose changes every four weeks

It is unknown whether semaglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined.Semaglutide is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Postprandial Dosing You can inject semaglutide on an empty stomach or after a light meal

If these side effects persist or worsen, its crucial to inform your healthcare provider

Story Source: Materials provided by BMC (BioMed Central)